Journal Information
ISSN / EISSN : 2150-7511 / 2150-7511
Published by: American Society for Microbiology (10.1128)
Total articles ≅ 5,159
Current Coverage
SCOPUS
SCIE
LOCKSS
MEDICUS
MEDLINE
PUBMED
PMC
DOAJ
Archived in
SHERPA/ROMEO
Filter:

Latest articles in this journal

Li Wang, Isabel Sola, , Sonia Zuñiga
Published: 14 September 2021
Abstract:
Coronaviruses (CoVs) are emerging pathogens causing life-threatening diseases in humans. Knowledge of virus-host interactions and viral subversion mechanisms of host pathways is required for the development of effective countermeasures against CoVs.
Christopher N. Vassallo, Govind Prasad Sah, Michael L. Weltzer,
Published: 14 September 2021
Abstract:
Many bacterial species use diverse systems to deliver bacteriocins or toxins to neighboring competing cells. These systems are often selective in targeting cells that are related to themselves and therefore compete in the same niches for resources.
Anil Pant, Lara Dsouza,
Published: 14 September 2021
Abstract:
Cellular activities are finely regulated by numerous signaling pathways to support specific functions of complex life processes. Viruses are obligate intracellular parasites.
Mingi Kim, Do Young Kim, Woon Young Song, So Eun Park, Simone A. Harrison, Walter J. Chazin, Man Hwan Oh,
Published: 14 September 2021
Abstract:
Acinetobacter baumannii has acquired antibiotic resistance at an alarming rate, and it is becoming a serious threat to society, particularly due to the paucity of effective treatment options. Acinetobactin is a siderophore of Acinetobacter baumannii , responsible for active iron supply, and it serves as a key virulence factor to counter host nutritional immunity during infection.
Anuj Tripathi, Ujjal K. Singha, Ayorinde Cooley, Taneisha Gillyard, Evan Krystofiak, Siddharth Pratap, Jamaine Davis,
Published: 14 September 2021
Abstract:
African trypanosomiasis is a neglected tropical disease caused by the parasitic protozoan Trypanosoma brucei . During its digenetic life cycle, T. brucei undergoes multiple developmental changes to adapt in different environments. T. brucei BF parasites, dwelling in mammalian blood, produce ATP from glycolysis and hydrolyze ATP in mitochondria for generation of inner membrane potential.
Chih-Feng Wu, , , Lin Chou, Surtaz Khan, , ,
Published: 14 September 2021
Abstract:
The T6SS is used by several taxa of Gram-negative bacteria to secrete toxic effector proteins to attack others. Diversification of effector collections shapes bacterial interactions and impacts the health of hosts and ecosystems in which bacteria reside.
Samane Rahmdel,
Published: 14 September 2021
Abstract:
The stratum corneum is the outermost layer of the epidermis and is thus directly exposed to the environment. It consists mainly of corneocytes, which are keratinocytes in the last stage of differentiation, having neither nuclei nor organelles.
Karen Ross, , Erik Snesrud, Hongzhan Huang, , Jian Zhang, , ,
Published: 14 September 2021
Abstract:
The ability of bacteria to undergo rapid evolution and adapt to changing environmental circumstances drives the public health crisis of multiple antibiotic resistance, as well as outbreaks of disease in economically important agricultural crops and animal husbandry. Prokaryotic transposable elements (TE) play a critical role in this.
Published: 14 September 2021
Abstract:
Marine sponges often form symbiotic relationships with bacteria that fulfil a specific need within the sponge holobiont, and these symbionts are often conserved within a narrow range of related taxa. To date, there exist only three known bacterial taxa ( Entoporibacteria , SAUL , and Tethybacterales ) that are globally distributed and found in a broad range of sponge hosts, and little is known about the latter two.
Wen Su, Sin Fun Sia, Aaron J. Schmitz, Traci L. Bricker, Tyler N. Starr, Allison J. Greaney, Jackson S. Turner, Bassem M. Mohammed, Zhuoming Liu, Ka Tim Choy, et al.
Published: 14 September 2021
Abstract:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein is the main target for neutralizing antibodies. These antibodies can be elicited through immunization or passively transferred as therapeutics in the form of convalescent-phase sera or monoclonal antibodies (MAbs).
Back to Top Top